BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 18191286)

  • 1. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom.
    Cannon R; Ruha AM; Kashani J
    Ann Emerg Med; 2008 Apr; 51(4):407-11. PubMed ID: 18191286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
    Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
    Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri).
    Bush SP; Green SM; Moynihan JA; Hayes WK; Cardwell MD
    Ann Emerg Med; 2002 Dec; 40(6):619-24. PubMed ID: 12447339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.
    Lavonas EJ; Kokko J; Schaeffer TH; Mlynarchek SL; Bogdan GM; Dart RC
    Ann Emerg Med; 2011 Feb; 57(2):128-137.e3. PubMed ID: 20952098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
    Fazelat J; Teperman SH; Touger M
    Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use and tolerability of Crotalidae Polyvalent Immune FAB (Ovine) in pediatric envenomations.
    Farrar HC; Grayham T; Bolden B; Vyas D; Graham J; James LP
    Clin Pediatr (Phila); 2012 Oct; 51(10):945-9. PubMed ID: 22511193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite.
    Lavonas EJ; Gerardo CJ; O'Malley G; Arnold TC; Bush SP; Banner W; Steffens M; Kerns WP
    Ann Emerg Med; 2004 Feb; 43(2):200-6. PubMed ID: 14747809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.
    Ruha AM; Curry SC; Albrecht C; Riley B; Pizon A
    Toxicon; 2011 Jan; 57(1):53-9. PubMed ID: 20920516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.
    Keating GM
    BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children.
    Johnson PN; McGoodwin L; Banner W
    Emerg Med J; 2008 Dec; 25(12):793-8. PubMed ID: 19033492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation.
    Goto CS; Feng SY
    Pediatr Emerg Care; 2009 Apr; 25(4):273-9; quiz 280-2. PubMed ID: 19369845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent coagulopathy and thrombocytopenia in children treated with crotalidae polyvalent immune fab: a case series.
    Miller AD; Young MC; DeMott MC; Ly BT; Clark RF
    Pediatr Emerg Care; 2010 Aug; 26(8):576-82. PubMed ID: 20693856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
    Bush SP; Seifert SA; Oakes J; Smith SD; Phan TH; Pearl SR; Reibling ET
    Toxicon; 2013 Jul; 69():29-37. PubMed ID: 23474267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom.
    Clark RF; McKinney PE; Chase PB; Walter FG
    Ann Emerg Med; 2002 Jun; 39(6):671-6. PubMed ID: 12023714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation.
    Ruha AM; Curry SC; Beuhler M; Katz K; Brooks DE; Graeme KA; Wallace K; Gerkin R; Lovecchio F; Wax P; Selden B
    Ann Emerg Med; 2002 Jun; 39(6):609-15. PubMed ID: 12023703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center.
    Weant KA; Bowers RC; Reed J; Braun KA; Dodd DM; Baker SN
    Pharmacotherapy; 2012 May; 32(5):433-40. PubMed ID: 22467377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis.
    Schaeffer TH; Khatri V; Reifler LM; Lavonas EJ
    Acad Emerg Med; 2012 Feb; 19(2):121-31. PubMed ID: 22320362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snake venom or antivenom induced urticaria.
    Keyler DE; Steinberg P
    Vet Hum Toxicol; 1991 Jun; 33(3):283-4. PubMed ID: 1858314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized multicenter trial of Crotalidae polyvalent immune F(ab) antivenom for the treatment of rattlesnake envenomation in dogs.
    Peterson ME; Matz M; Seibold K; Plunkett S; Johnson S; Fitzgerald K
    J Vet Emerg Crit Care (San Antonio); 2011 Aug; 21(4):335-45. PubMed ID: 21827591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation.
    Offerman SR; Bush SP; Moynihan JA; Clark RF
    Pediatrics; 2002 Nov; 110(5):968-71. PubMed ID: 12415038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.